A Single-Dose, 2-Period, 2-Treatment, 2-Way Crossover Bioequivalency Study of Ropinirole 0.25 mg Tablets Under Fed Conditions

Clinical trial NCT00674310 · COMPLETED

Trial details

NCT number: NCT00674310
Sponsor: Roxane Laboratories
Status: COMPLETED
Phase: Not Applicable
Study type: INTERVENTIONAL

Parkinson's Disease Restless Leg Syndrome

Start date: 2004-02-01
Primary completion: 2004-02-01
Enrollment: 29

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.